• Study Identifies Treatments That Reduce Acute Attacks in HAE Patients With Plasminogen Mutation
  • Preventive Treatment with Berotralstat Lowers HAE Attack Rate, BioCryst Says
  • New Production Facility for Ruconest, Pharming’s Acute HAE Treatment, Gets FDA Nod
  • Pediatric Rare Disease Therapies Increase, But Most Repurposed, Study Finds
  • Video: BioNews’ Social Media Campaign Highlights #WhatMakesMeRare
  • Mutations May Raise Risk of Angioedema Linked to Blood Pressure Medicines
  • Test Using Dried Blood Spot May Be Simple Way to Diagnose HAE
  • Elsevier Opens Books, Review Articles to Rare Disease Researchers Starting Feb. 29
  • Advice on Starting Nonprofit Groups for Rare and Other Diseases Focus of NORD Webinar
  • FDA Agrees to Review Berotralstat as Preventive Treatment for HAE Attacks
  • Patients, Supporters Worldwide Recognizing Rare Disease Day 2020
  • Ruconest Safe, Effective for On-demand and Preventive Treatment of HAE Attacks, Study Says